Tirzepatide produces better outcomes than any non-surgical alternative at comparable or lower total cost
Indications: FDA approved: Type II diabetes - monotherapy or combination therapy Can be combined as adjunct therapy with other hypoglycemics including metformin, thiazolidinediones, or insulin regimens (Dungan & DeSantis 2015) Because it does not work when your blood sugar is low, it is unlikely to produce dangerous levels of hypoglycemia has been observed in clinical trials (in contrast to GLP-1 incretin mimetics, such as exenatide, which produce moderate weight loss)
These medications can sometimes affect the skin by increasing dryness, sensitivity, or changes in elasticity
reduced energy intake generally lowers heat production, and changes in perspiration are more often driven by activity levels, diet composition, and individual factors
Highland Longevity offers telehealth follow-up appointments for tirzepatide patients throughout the DFW Metroplex
What If: Cagrilintide Protocol Scenarios What If I Experience Severe Nausea at 1.2mg Weekly
.webp)
